Federal government now searching for Johnson and Johnson vaccine after donating 10 million doses in summer - National Post | Canada News Media
Connect with us

Business

Federal government now searching for Johnson and Johnson vaccine after donating 10 million doses in summer – National Post

Published

 on


Alberta and Saskatchewan have both asked for J&J doses to reach vaccine hesitant people who don’t want to take mRNA vaccines

Article content

OTTAWA – The federal government said it donated a contract for ten million doses of Johnson & Johnson’s COVID-19 vaccine earlier this year after getting a clear sign from provinces that they weren’t interested in the vaccine.

Advertisement

Article content

But now, faced with a small number of vaccine hesitant individuals waiting for the shot, the government is searching for J&J doses.

One senior government official who spoke to the National Post on the condition they not be named, said they focused on Pfizer and Moderna deliveries because that was what provinces and the public were looking for.

“Provinces and territories told us they didn’t want Johnson & Johnson,” they said.

On August 12, the government announced Canada’s 10 million-dose order of Johnson & Johnson vaccines would be donated to COVAX, an international group pushing to vaccinate the developing world. The source said that donation was made with the provinces’ consent but stressed the provinces were just adapting to a changing situation.

Advertisement

Article content

“They are allowed to change their mind.”

Johnson & Johnson has not yet delivered on that shipment, so it might be possible to get some of the COVAX doses diverted to Canada when the delivery comes through, but the government is also looking elsewhere.


  1. Not everyone wants a Pfizer or Moderna COVID vaccine. So offer them something else


  2. Canada to donate 10 million unused J&J vaccine doses to low-income countries

Alberta and Saskatchewan have both asked the federal government for Johnson & Johnson doses to reach vaccine hesitant people who don’t want to take mRNA vaccines like Pfizer and Moderna.

Alberta Health spokesperson Lisa Glover said they have asked the federal government for some of the doses, hoping to get more people vaccinated.

Advertisement

Article content

“Alberta has requested up to 20,000 doses of Janssen vaccine, when safely available. We and several other provinces are in discussions with the National Operations Centre, and we’re hopeful that we’ll receive an initial supply soon,” she said.

The federal government ordered hundreds of millions of doses of COVID-19 vaccines from multiple companies, but the vast majority of the shots that actually went into Canadians arms were either Pfizer or Moderna.

The mRNA vaccines are safe and highly effective against the virus, but some vaccine hesitant people have expressed concern because the vaccines are based on a relatively new technology. Online conspiracies have suggested the mRNA vaccines can alter DNA, but that is not supported by science.

Advertisement

Article content

Johnson & Johnson was the fourth vaccine maker to receive regulatory approval in Canada and an initial delivery of 300,000 doses was received in April, but U.S. regulators later uncovered quality control issues with the manufacturing facilities for those vaccines and the government didn’t distribute those doses.

The company is expected to have more doses of its vaccine in the fall, but it cut its original production estimate for this year in half.

While the company worked to resolve its manufacturing issues, Canada was flooded with doses from Pfizer and Moderna, tens of millions of shots in May, June and July, allowing most Canadians to get vaccinated and giving Canada one of the highest vaccination rates in the world.

Advertisement

Article content

Johnson & Johnson’s vaccine initially showed it had a 66 per cent efficacy rate at preventing people from getting COVID-19, lower than Pfizer or Modena, but it was shown to be nearly 100 per cent effective at preventing hospitalization.

The vaccine was initially planned as a single dose regimen, but the company recently applied to American regulators to have it given as a booster shot, with a second dose increasing the vaccine’s effectiveness.

The government also had large contracts for AstraZeneca vaccines and imported about two million doses of that shot, but most provinces stopped administering it after concerns arose about extremely rare blood clots.

Despite those concerns, the AstraZeneca vaccine was the workhorse of the U.K.’s vaccine rollout, helping that country get widespread coverage earlier than most nations.

Canada is also waiting on other vaccines from Novavax and Medicago, two other vaccines that are still in the regulatory review stage.

Both companies have submitted some data on their vaccines, but Health Canada is awaiting additional information from both firms.

• Email: rtumilty@postmedia.com | Twitter:

Advertisement

Comments

Postmedia is committed to maintaining a lively but civil forum for discussion and encourage all readers to share their views on our articles. Comments may take up to an hour for moderation before appearing on the site. We ask you to keep your comments relevant and respectful. We have enabled email notifications—you will now receive an email if you receive a reply to your comment, there is an update to a comment thread you follow or if a user you follow comments. Visit our Community Guidelines for more information and details on how to adjust your email settings.

Adblock test (Why?)



Source link

Continue Reading

Business

Transat AT reports $39.9M Q3 loss compared with $57.3M profit a year earlier

Published

 on

 

MONTREAL – Travel company Transat AT Inc. reported a loss in its latest quarter compared with a profit a year earlier as its revenue edged lower.

The parent company of Air Transat says it lost $39.9 million or $1.03 per diluted share in its quarter ended July 31.

The result compared with a profit of $57.3 million or $1.49 per diluted share a year earlier.

Revenue in what was the company’s third quarter totalled $736.2 million, down from $746.3 million in the same quarter last year.

On an adjusted basis, Transat says it lost $1.10 per share in its latest quarter compared with an adjusted profit of $1.10 per share a year earlier.

Transat chief executive Annick Guérard says demand for leisure travel remains healthy, as evidenced by higher traffic, but consumers are increasingly price conscious given the current economic uncertainty.

This report by The Canadian Press was first published Sept. 12, 2024.

Companies in this story: (TSX:TRZ)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Dollarama keeping an eye on competitors as Loblaw launches new ultra-discount chain

Published

 on

 

Dollarama Inc.’s food aisles may have expanded far beyond sweet treats or piles of gum by the checkout counter in recent years, but its chief executive maintains his company is “not in the grocery business,” even if it’s keeping an eye on the sector.

“It’s just one small part of our store,” Neil Rossy told analysts on a Wednesday call, where he was questioned about the company’s food merchandise and rivals playing in the same space.

“We will keep an eye on all retailers — like all retailers keep an eye on us — to make sure that we’re competitive and we understand what’s out there.”

Over the last decade and as consumers have more recently sought deals, Dollarama’s food merchandise has expanded to include bread and pantry staples like cereal, rice and pasta sold at prices on par or below supermarkets.

However, the competition in the discount segment of the market Dollarama operates in intensified recently when the country’s biggest grocery chain began piloting a new ultra-discount store.

The No Name stores being tested by Loblaw Cos. Ltd. in Windsor, St. Catharines and Brockville, Ont., are billed as 20 per cent cheaper than discount retail competitors including No Frills. The grocery giant is able to offer such cost savings by relying on a smaller store footprint, fewer chilled products and a hearty range of No Name merchandise.

Though Rossy brushed off notions that his company is a supermarket challenger, grocers aren’t off his radar.

“All retailers in Canada are realistic about the fact that everyone is everyone’s competition on any given item or category,” he said.

Rossy declined to reveal how much of the chain’s sales would overlap with Loblaw or the food category, arguing the vast variety of items Dollarama sells is its strength rather than its grocery products alone.

“What makes Dollarama Dollarama is a very wide assortment of different departments that somewhat represent the old five-and-dime local convenience store,” he said.

The breadth of Dollarama’s offerings helped carry the company to a second-quarter profit of $285.9 million, up from $245.8 million in the same quarter last year as its sales rose 7.4 per cent.

The retailer said Wednesday the profit amounted to $1.02 per diluted share for the 13-week period ended July 28, up from 86 cents per diluted share a year earlier.

The period the quarter covers includes the start of summer, when Rossy said the weather was “terrible.”

“The weather got slightly better towards the end of the summer and our sales certainly increased, but not enough to make up for the season’s horrible start,” he said.

Sales totalled $1.56 billion for the quarter, up from $1.46 billion in the same quarter last year.

Comparable store sales, a key metric for retailers, increased 4.7 per cent, while the average transaction was down2.2 per cent and traffic was up seven per cent, RBC analyst Irene Nattel pointed out.

She told investors in a note that the numbers reflect “solid demand as cautious consumers focus on core consumables and everyday essentials.”

Analysts have attributed such behaviour to interest rates that have been slow to drop and high prices of key consumer goods, which are weighing on household budgets.

To cope, many Canadians have spent more time seeking deals, trading down to more affordable brands and forgoing small luxuries they would treat themselves to in better economic times.

“When people feel squeezed, they tend to shy away from discretionary, focus on the basics,” Rossy said. “When people are feeling good about their wallet, they tend to be more lax about the basics and more willing to spend on discretionary.”

The current economic situation has drawn in not just the average Canadian looking to save a buck or two, but also wealthier consumers.

“When the entire economy is feeling slightly squeezed, we get more consumers who might not have to or want to shop at a Dollarama generally or who enjoy shopping at a Dollarama but have the luxury of not having to worry about the price in some other store that they happen to be standing in that has those goods,” Rossy said.

“Well, when times are tougher, they’ll consider the extra five minutes to go to the store next door.”

This report by The Canadian Press was first published Sept. 11, 2024.

Companies in this story: (TSX:DOL)

Source link

Continue Reading

Business

U.S. regulator fines TD Bank US$28M for faulty consumer reports

Published

 on

 

TORONTO – The U.S. Consumer Financial Protection Bureau has ordered TD Bank Group to pay US$28 million for repeatedly sharing inaccurate, negative information about its customers to consumer reporting companies.

The agency says TD has to pay US$7.76 million in total to tens of thousands of victims of its illegal actions, along with a US$20 million civil penalty.

It says TD shared information that contained systemic errors about credit card and bank deposit accounts to consumer reporting companies, which can include credit reports as well as screening reports for tenants and employees and other background checks.

CFPB director Rohit Chopra says in a statement that TD threatened the consumer reports of customers with fraudulent information then “barely lifted a finger to fix it,” and that regulators will need to “focus major attention” on TD Bank to change its course.

TD says in a statement it self-identified these issues and proactively worked to improve its practices, and that it is committed to delivering on its responsibilities to its customers.

The bank also faces scrutiny in the U.S. over its anti-money laundering program where it expects to pay more than US$3 billion in monetary penalties to resolve.

This report by The Canadian Press was first published Sept. 11, 2024.

Companies in this story: (TSX:TD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version